Clik here to view.
LabCorp Completes Acquisition of Assets of Mount Sinai Health System Clinical...
Monday, May 1st 2017 at 12:45pm UTC Transaction will benefit physicians and patients in metropolitan New York City BURLINGTON, N.C.–(BUSINESS WIRE)– LabCorp® (NYSE: LH), a leading global life sciences...
View ArticleClik here to view.
22nd Century Group Files 2017 First Quarter Report and Announces Conference...
Monday, May 8th 2017 at 8:15pm UTC Company now projecting substantially higher 2017 revenue FDA will discuss three important 22nd Century proprietary products CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd...
View ArticleClik here to view.
Zymeworks to Present at UBS Global Healthcare Conference
Friday, May 12th 2017 at 11:00am UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (“Zymeworks”) (NYSE:ZYME; TSX:ZYME) a clinical-stage biopharmaceutical company dedicated to the...
View ArticleClik here to view.
Cellectis Reports 1st Quarter 2017 Financial Results
Tuesday, May 9th 2017 at 8:30pm UTC – Clinical trial approval by the FDA for wholly-owned UCART123 in AML & BPDCN patients at Weill Cornell and MD Anderson – IND clearance granted by the FDA to...
View ArticleClik here to view.
Kristin Neuman Hablará Sobre la Licencia Conjunta CRISPR de MPEG LA en...
Wednesday, May 10th 2017 at 1:00pm UTC DENVER–(BUSINESS WIRE)– El líder mundial en otorgamiento de licencias MPEG LA, LLC anunció hoy que Kristin Neuman, Directora Ejecutiva de Licencias de...
View ArticleClik here to view.
SERMO présente le premier outil de notation de médicament réservé aux médecins
Wednesday, May 10th 2017 at 1:04pm UTC Baptisé « Drug Ratings », ce nouvel outil donne aux docteurs une capacité inégalée pour rechercher, choisir et échanger des avis pour des médicaments sur...
View ArticleClik here to view.
Kristin Neuman va exposer le programme de licences conjointes CRISPR de MPEG...
Wednesday, May 10th 2017 at 1:00pm UTC DENVER–(BUSINESS WIRE)– Le leader mondial des licences MPEG LA, LLC a annoncé aujourd’hui que Kristin Neuman, directrice exécutive des licences de biotechnologie...
View ArticleClik here to view.
PIN Pharma to Present a Poster at AACR International Conference on...
Friday, May 5th 2017 at 5:44pm UTC NEW YORK–(BUSINESS WIRE)– PIN Pharma, a pre-clinical immunotherapy company focused on modulating the immune system in oncology, today announced the Company will be...
View ArticleClik here to view.
CheckedUp and TearScience® Team Up to Impact Dry Eye Patient Education
Saturday, May 6th 2017 at 12:00pm UTC – Partnership brings CheckedUp Platform to hundreds of clinics nationwide – NEW YORK–(BUSINESS WIRE)– CheckedUp, a specialty point of care company, today...
View ArticleClik here to view.
Marrone Bio Innovations, Inc. Reports 2017 First Quarter Results
Thursday, May 11th 2017 at 8:05pm UTC First Quarter GAAP Revenues Increase 56% to $4.2 million First Quarter Product Shipments Increase 66% to Record Level of $6.5 million Closes Secondary Offering...
View ArticleClik here to view.
Ipsen Completes Acquisition of Select Consumer Healthcare Products from Sanofi
Monday, May 8th 2017 at 6:00am UTC PARIS–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announced...
View ArticleClik here to view.
RaNA Therapeutics to Present at 2017 UBS Global Healthcare Conference
Monday, May 15th 2017 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced the...
View ArticleClik here to view.
Lazard Releases Global Healthcare Leaders Study
Monday, May 15th 2017 at 10:00am UTC – Senior decision-makers say pricing pressure is top strategic challenge – – Scientific and business model innovation central to meet the challenge – – New...
View ArticleClik here to view.
Teva Announces Launch of Generic Glumetza® in the United States
Monday, May 15th 2017 at 5:20pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Glumetza®1 (metformin hydrochloride...
View ArticleClik here to view.
Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine...
Monday, May 15th 2017 at 12:00pm UTC TOKYO & JERUSALEM–(BUSINESS WIRE)– Otsuka Pharmaceutical Co., Ltd (Otsuka) and Teva Pharmaceutical Industries, Ltd. (Teva) announce an agreement covering Japan...
View ArticleClik here to view.
Novocure™ Receives Humanitarian Use Device Designation for Treatment of...
Monday, May 15th 2017 at 11:25am UTC ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that United States Food and Drug Administration (FDA) has designated it’s Tumor Treating...
View ArticleClik here to view.
Kadmon Provides Business Update and Reports First Quarter 2017 Financial Results
Monday, May 15th 2017 at 1:00pm UTC — Continuing to Streamline Operations While Advancing Clinical Pipeline — NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) (“Kadmon” or the “Company”)...
View ArticleClik here to view.
Acorda to Present New INBRIJA™ (Levodopa Inhalation Powder) Phase 3 Data at...
Thursday, May 18th 2017 at 11:00am UTC Company to host investor webcast to review data from INBRIJA (CVT-301) clinical program on Monday, June 5 at 4:30 pm Eastern / 1:30 pm Pacific ARDSLEY,...
View ArticleClik here to view.
Millendo Therapeutics to Present at the UBS Global Healthcare Conference
Wednesday, May 17th 2017 at 11:00am UTC ANN ARBOR, Mich.–(BUSINESS WIRE)– Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for endocrine...
View ArticleClik here to view.
Medytox to Further Expand Global Presence by Increasing Its Adoption of the...
Monday, May 15th 2017 at 9:30pm UTC Global Biopharmaceutical Company to Become the First in Korea to Adopt Medidata’s Risk-based Monitoring Solution for Its Major Clinical Trials Medytox Aims to...
View Article